Integra LifeSciences Holdings: A 14.2% Better Bargain Than When Ballintyn Bought
May 15, 2019 at 10:01 AM EDT
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on March 14, Integra LifeSciences Holdings Corp's Director, Rhonda Germany Ballintyn, invested $108,399.16 into 1,933 shares of IART, for a cost per share of $56.08..
